Antibodies
The new vaccine strategy is based on the HIV envelope protein, Env
Rutgers researcher leads team analyzing more exact methods to diagnose the most common tick-borne infection
Two new studies are bringing Ebola virus's weaknesses into the spotlight
Biochemical assays are dependent on the fidelity with which one can quantify the relative concentrations of proteins in solution.
New kits enable easy, fast labeling of primary antibodies or proteins with Alexa Fluor 647, 700, 555, 568, and 694
NIH scientists suspect process aims to curb immune-system hyperactivity
Researchers are a step closer to developing a broadly effective antibody treatment against the three major Ebola viruses that cause lethal disease in humans
Monoclonal antibodies are proteins manufactured in the laboratory that can target specific disease cells, viruses, and other antigens
Drug discovery and development is a long, expensive and complicated process
IONTAS Limited announced it has signed a collaboration agreement with Korean-based LG Chem, Ltd.
Funding will be used to further develop IONTAS’ ion-channel targeting KnotBody antibody platform to block pain transmission via Nav1.7
Sustained production of Affimer drugs by muscle tissue in vivo could lead to major patient and commercial benefits
